Mizuho Securities Lowers Adjusts Price Target on Sage Therapeutics to $16 From $18, Maintains Neutral Rating
Mizuho Securities Lowers Adjusts Price Target on Sage Therapeutics to $16 From $18, Maintains Neutral Rating
瑞穗證券將sage therapeutics的目標價格調整爲16美元，降自18美元，保持中立評級。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊